Hexose-6-phosphate dehydrogenase determines the reaction direction of 11β-hydroxysteroid dehydrogenase type 1 as an oxoreductase

被引：192

作者：

Atanasov, AG ^{[1
]}

Nashev, LG ^{[1
]}

Schweizer, RAS ^{[1
]}

Frick, C ^{[1
]}

Odermatt, A ^{[1
]}

机构：

[1] Univ Bern, Dept Clin Res, Div Nephrol & Hypertens, CH-3010 Bern, Switzerland

来源：

FEBS LETTERS | 2004年 / 571卷 / 1-3期

关键词：

11 beta-hydroxysteroid dehydrogenase; hexose-6-phosphate dehydrogenase; glucocorticoid; cortisol;

D O I：

10.1016/j.febslet.2004.06.065

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

The impact of hexose-6-phosphate dehydrogenase (H6PDH) on 11beta-hydroxysteroid dehydrogenase (11beta-HSD) type 1 activity was investigated upon coexpression in HEK-293 cells. Confocal microscopy analysis indicated colocalisation of both enzymes at the lumenal side of the endoplasmic reticulum (ER) membrane. Functional analysis in intact cells revealed fivefold stimulation of 11beta-HSD1 oxoreductase activity and sixfold decrease of dehydrogenase activity upon coexpression with H6PDH, without changing kinetic parameters in cell lysates. Thus, H6PDH directly determines the reaction direction of 11beta-HSD1 in intact cells as an oxoreductase without changing intrinsic catalytic properties of 11beta-HSD1 by regenerating NADPH in the ER-lumen. (C) 2004 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

引用

页码：129 / 133

页数：5

共 23 条

[1] BANHEGYI G, 2004, J BIOL CHEM
[2] A switch in dehydrogenase to reductase activity of 11,6-hydroxysteroid dehydrogenase type 1 upon differentiation of human omental adipose stromal cells
Bujalska, IJ
Walker, EA
Hewison, M
Stewart, PM
[J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (03) : 1205 - 1210
[3] Does central obesity reflect ''Cushing's disease of the omentum''?
Bujalska, IJ
Kumar, S
Stewart, PM
[J]. LANCET, 1997, 349 (9060) : 1210 - 1213
[4] Mutations in the genes encoding 11β-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase interact to cause cortisone reductase deficiency
Draper, N
Walker, EA
Bujalska, IJ
Tomlinson, JW
Chalder, SM
Arlt, W
Lavery, GG
Bedendo, O
Ray, DW
Laing, I
Malunowicz, E
White, PC
Hewison, M
Mason, PJ
Connell, JM
Shackleton, CHL
Stewart, PM
[J]. NATURE GENETICS, 2003, 34 (04) : 434 - 439
[5] Suppression of endogenous corticosterone levels in vivo increases the steroidogenic capacity of purified rat Leydig cells in vitro
Gao, HB
Shan, LX
Monder, C
Hardy, MP
[J]. ENDOCRINOLOGY, 1996, 137 (05) : 1714 - 1718
[6] Developmental changes in glucocorticoid receptor and 11 beta-hydroxysteroid dehydrogenase oxidative and reductive activities in rat Leydig cells
Ge, RS
Hardy, DO
Catterall, JF
Hardy, MP
[J]. ENDOCRINOLOGY, 1997, 138 (12) : 5089 - 5095
[7] REGULATION OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE-ACTIVITY IN HUMAN SKIN FIBROBLASTS - ENZYMATIC MODULATION OF GLUCOCORTICOID ACTION
HAMMAMI, MM
SIITERI, PK
[J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1991, 73 (02) : 326 - 334
[8] LATENCY OF MICROSOMAL HEXOSE-6-PHOSPHATE DEHYDROGENASE-ACTIVITY
HORI, SH
TAKAHASHI, T
[J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1977, 496 (01) : 1 - 11
[9] Apparent cortisone reductase deficiency:: A functional defect in 11β-hydroxysteroid dehydrogenase type 1
Jamieson, A
Wallace, AM
Andrew, R
Nunez, BS
Walker, BR
Fraser, R
White, PC
Connell, JMC
[J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (10) : 3570 - 3574
[10] 11β-Hydroxysteroid dehydrogenase type 1 is a predominant 11β-reductase in the intact perfused rat liver
Jamieson, PM
Walker, BR
Chapman, KE
Andrew, R
Rossiter, S
Seckl, JR
[J]. JOURNAL OF ENDOCRINOLOGY, 2000, 165 (03) : 685 - 692

← 1 2 3 →